MPLT Maplight Therapeutics Inc.

• $175M bought by 5 insiders
• None no sales outside a trading plan
• $17.5M sold by 8 insiders under 10b5-1 plans

1. Insider
   Trade
   Value
   Traded, filed
2. Kristopher Hanson General Counsel
   Planned sale
   $193K 16,509 shares at $11.67 11% of stake
   Traded Sep 16 Filed Sep 18
   ↗
3. Catalyst4, Inc. 10% owner
   Buy
   $50.1M 4,400,000 shares at $11.38 +21% to stake
   Traded Aug 14 Filed Aug 18
   ↗
4. James Woodruff Lillie Chief Scientific Officer
   Planned sale
   $277K 22,082 shares at $12.54 9.8% of stake
   Traded Aug 3 Filed Aug 4
   ↗
5. Catalyst4, Inc. 10% owner
   Buy
   $15.3M 1,209,225 shares at $12.66 +6.1% to stake
   Traded Jul 28–30 Filed Jul 30
   ↗
6. Troy Cox Director
   Buy
   $149K 15,620 shares at $9.52 New stake
   Traded Jul 28 Filed Jul 28
   ↗
7. Anatol Kreitzer Chief Discovery Officer
   Planned sale
   $646K 17,173 shares at $37.60 8.9% of stake
   Traded Jul 17 Filed Jul 20
   ↗
8. Jonathan Gillis CFO
   Planned sale
   $694K 18,469 shares at $37.60 11% of stake
   Traded Jul 17 Filed Jul 20
   ↗
9. Erin Pennock Foff Chief Medical Officer
   Planned sale
   $549K 15,000 shares at $36.62 4.3% of stake
   Traded Jul 15 Filed Jul 17
   ↗
10. Christopher A. Kroeger CEO
    Planned sale
    $3.2M 118,235 shares at $27.19 7.8% of stake
    Traded May 18 Filed May 18
    ↗
11. Erin Pennock Foff Chief Medical Officer
    Planned sale
    $127K 4,438 shares at $28.54 1.3% of stake
    Traded May 7 Filed May 11
    ↗
12. Kristopher Hanson General Counsel
    Planned sale
    $419K 13,917 shares at $30.13 7.9% of stake
    Traded May 11 Filed May 11
    ↗
13. James Woodruff Lillie Chief Scientific Officer
    Planned sale
    $20K 721 shares at $28.28 0.3% of stake
    Traded May 7 Filed May 11
    ↗
14. Christopher A. Kroeger CEO
    Planned sale
    $1.9M 68,491 shares at $28.47 4.3% of stake
    Traded May 7–11 Filed May 11
    ↗
15. Vishwas Setia CFO
    Planned sale
    $1M 36,371 shares at $28.17 9.3% of stake
    Traded May 4–6 Filed May 6
    ↗
16. Erin Pennock Foff Chief Medical Officer
    Planned sale
    $1.4M 50,280 shares at $28.39 13% of stake
    Traded May 4–6 Filed May 6
    ↗

Also filed in the last 12 months, not counted as buying or selling: 72 sales to cover taxes, 20 stock grants, 7 share withholdings for taxes, and 4 conversions.